These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 11889163)
1. Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women. Christian RC; Harrington S; Edwards WD; Oberg AL; Fitzpatrick LA J Clin Endocrinol Metab; 2002 Mar; 87(3):1062-7. PubMed ID: 11889163 [TBL] [Abstract][Full Text] [Related]
2. Intimal estrogen receptor (ER)beta, but not ERalpha expression, is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women. Christian RC; Liu PY; Harrington S; Ruan M; Miller VM; Fitzpatrick LA J Clin Endocrinol Metab; 2006 Jul; 91(7):2713-20. PubMed ID: 16608893 [TBL] [Abstract][Full Text] [Related]
3. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. Sangiorgi G; Rumberger JA; Severson A; Edwards WD; Gregoire J; Fitzpatrick LA; Schwartz RS J Am Coll Cardiol; 1998 Jan; 31(1):126-33. PubMed ID: 9426030 [TBL] [Abstract][Full Text] [Related]
4. Comparison of progression of coronary calcium in postmenopausal women on versus not on estrogen/progestin therapy. Becker A; Leber A; von Ziegler F; Becker C; Knez A Am J Cardiol; 2007 Feb; 99(3):374-8. PubMed ID: 17261401 [TBL] [Abstract][Full Text] [Related]
6. The perimenopausal atherosclerosis transition: relationships between calcified and noncalcified coronary, aortic, and carotid atherosclerosis and risk factors and hormone levels. Munir JA; Wu H; Bauer K; Bindeman J; Byrd C; Feuerstein IM; Villines TC; Taylor AJ Menopause; 2012 Jan; 19(1):10-5. PubMed ID: 21900851 [TBL] [Abstract][Full Text] [Related]
7. Correlating androgen and estrogen steroid receptor expression with coronary calcification and atherosclerosis in men without known coronary artery disease. Liu PY; Christian RC; Ruan M; Miller VM; Fitzpatrick LA J Clin Endocrinol Metab; 2005 Feb; 90(2):1041-6. PubMed ID: 15536156 [TBL] [Abstract][Full Text] [Related]
8. Effect of menopause on plaque morphologic characteristics in coronary atherosclerosis. Burke AP; Farb A; Malcom G; Virmani R Am Heart J; 2001 Feb; 141(2 Suppl):S58-62. PubMed ID: 11174360 [TBL] [Abstract][Full Text] [Related]
9. Plaque in superficial femoral arteries indicates generalized atherosclerosis and vulnerability to coronary death: an autopsy study. Dalager S; Falk E; Kristensen IB; Paaske WP J Vasc Surg; 2008 Feb; 47(2):296-302. PubMed ID: 18241752 [TBL] [Abstract][Full Text] [Related]
10. Low dose estrogens inhibit coronary artery atherosclerosis in postmenopausal monkeys. Appt SE; Clarkson TB; Lees CJ; Anthony MS Maturitas; 2006 Sep; 55(2):187-94. PubMed ID: 16574351 [TBL] [Abstract][Full Text] [Related]
11. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Clarkson TB Menopause; 2018 Nov; 25(11):1262-1274. PubMed ID: 30358722 [TBL] [Abstract][Full Text] [Related]
12. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Clarkson TB Menopause; 2007; 14(3 Pt 1):373-84. PubMed ID: 17438515 [TBL] [Abstract][Full Text] [Related]
14. Calcium concentration of individual coronary calcified plaques as measured by multidetector row computed tomography. Moselewski F; O'Donnell CJ; Achenbach S; Ferencik M; Massaro J; Nguyen A; Cury RC; Abbara S; Jang IK; Brady TJ; Hoffmann U Circulation; 2005 Jun; 111(24):3236-41. PubMed ID: 15956133 [TBL] [Abstract][Full Text] [Related]
15. A histopathological analysis of the epidemiology of coronary atherosclerosis: an autopsy study. Abedinzadeh N; Pedram B; Sadeghian Y; Nodushan SM; Gilasgar M; Darvish M; Mokarizadeh A Diagn Pathol; 2015 Jul; 10():87. PubMed ID: 26137939 [TBL] [Abstract][Full Text] [Related]
16. Expression of estrogen receptors in the coronary arteries of young and premenopausal women in relation to central obesity. Kortelainen ML; Huttunen P Int J Obes Relat Metab Disord; 2004 Apr; 28(4):623-7. PubMed ID: 14758343 [TBL] [Abstract][Full Text] [Related]
17. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease. Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047 [TBL] [Abstract][Full Text] [Related]
18. Microvascular endoglin (CD105) expression correlates with tissue markers for atherosclerotic plaque vulnerability in an ageing population with multivessel coronary artery disease. Li X; van der Meer JJ; van der Loos CM; Ploegmakers HJ; de Boer OJ; de Winter RJ; van der Wal AC Histopathology; 2012 Jul; 61(1):88-97. PubMed ID: 22463585 [TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy is associated with less coronary atherosclerosis in postmenopausal women. Akhrass F; Evans AT; Wang Y; Rich S; Kannan CR; Fogelfeld L; Mazzone T J Clin Endocrinol Metab; 2003 Dec; 88(12):5611-4. PubMed ID: 14671142 [TBL] [Abstract][Full Text] [Related]
20. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. Herrington DM; Reboussin DM; Brosnihan KB; Sharp PC; Shumaker SA; Snyder TE; Furberg CD; Kowalchuk GJ; Stuckey TD; Rogers WJ; Givens DH; Waters D N Engl J Med; 2000 Aug; 343(8):522-9. PubMed ID: 10954759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]